NCT05891275View on ClinicalTrials.gov

Patients With Geographic Atrophy and Their Patient Journey in the United States (US)

CompletedOBSERVATIONAL
Enrollment

68,563

Participants

Timeline

Start Date

May 31, 2023

Primary Completion Date

December 1, 2023

Study Completion Date

December 1, 2023

Conditions
Geographic Atrophy
Trial Locations (1)

02451

CorEvitas HQ, Waltham

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT05891275 - Patients With Geographic Atrophy and Their Patient Journey in the United States (US) | Biotech Hunter | Biotech Hunter